Katarzyna Wnuk-Lipinska

Katarzyna Wnuk-Lipinska is a distinguished professional in oncology pharmacology with extensive experience in leading scientific research within the pharmaceutical industry. Currently serving as Lab Head and Principal Scientist II at Novartis since March 2021, Wnuk-Lipinska previously held senior roles at Ryvu Therapeutics and The Janssen Pharmaceutical Companies of Johnson & Johnson, where expertise in oncology pharmacology was developed. Early career positions included roles as Lead Scientist and Research Assistant at BerGenBio ASA, complemented by research fellowships at UT Southwestern Medical Center. Educational credentials include a PhD in Biomedicine from the University of Bergen, a Postgraduate Diploma in Industrial Pharmacy from Jagiellonian University, an MSc in Animal Breeding and Genetics from Wageningen University & Research, and an MSc Eng in Biotechnology from the University of Technology and Life Sciences in Bydgoszcz.